/22 0.80 1.00 0.19–3.40 Previous stroke 1/33 0 — 1.00 — Previous dopamine agonist therapy 2/33 2/22 0.65 1.00 0.08–4.96 Previous radiotherapy 1/33 0 — 1.00 — Acromegaly 0 1/22 — 1
Search Results
Fizzah Iqbal, William Adams, Ioannis Dimitropoulos, Samiul Muquit, and Daniel Flanagan
Ida Staby, Jesper Krogh, Marianne Klose, Jonas Baekdal, Ulla Feldt-Rasmussen, Lars Poulsgaard, Jacob Bertram Springborg, and Mikkel Andreassen
/oligomenorrhoea for premenopausal women. A diagnosis of Cushing’s disease or acromegaly was established according to the standard criteria. We did not report on GH deficiency or anti-diuretic hormone insufficiency because only a few patients were examined with GH
Jose M Garcia, Beverly M K Biller, Márta Korbonits, Vera Popovic, Anton Luger, Christian J Strasburger, Philippe Chanson, Ronald Swerdloff, Christina Wang, Rosa Rosanna Fleming, Fredric Cohen, Nicola Ammer, Gilbert Mueller, Nicky Kelepouris, Frank Strobl, Vlady Ostrow, and Kevin C J Yuen
data indicate that for the oral glucose tolerance test, BMI, sex, and use of oral contraceptives containing estradiol can significantly affect GH nadir levels, suggesting that the GH cutpoints used to diagnose acromegaly with this test may need to be
Yang Lv, Xu Han, Chunyan Zhang, Yuan Fang, Ning Pu, Yuan Ji, Dansong Wang, Xu Xuefeng, and Wenhui Lou
octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly . Clinical Endocrinology 2005 62 282 – 288 . ( https://doi.org/10.1111/j.1365-2265.2004.02191.x ) 10.1111/j.1365
Eva Jakobsson Ung, Ann-Charlotte Olofsson, Ida Björkman, Tobias Hallén, Daniel S Olsson, Oskar Ragnarsson, Thomas Skoglund, Sofie Jakobsson, and Gudmundur Johannsson
a 2 Other lesions in the pituitary b 4 Invasiveness (para sellar) 10 Surgical treatment Primary surgery, TS/TC 16/0 Re-surgery, TS/TC 2/1 a One patient with acromegaly and one with Cushing
Mark R Postma, Pia Burman, and André P van Beek
patients with a previous diagnosis of Cushing’s disease, acromegaly and craniopharyngioma because these conditions are known to affect body composition, cardiovascular risk factors and quality of life. For similar reasons of confounding bias, females
Ali Abbara, Sophie Clarke, Pei Chia Eng, James Milburn, Devavrata Joshi, Alexander N Comninos, Rozana Ramli, Amrish Mehta, Brynmor Jones, Florian Wernig, Ramesh Nair, Nigel Mendoza, Amir H Sam, Emma Hatfield, Karim Meeran, Waljit S Dhillo, and Niamh M Martin
acromegaly patient with pituitary macroadenoma . Endocrinology, Diabetes and Metabolism Case Reports 2017 17-0044. ( https://doi.org/10.1530/EDM-17-0044 ) 30 Verbalis JG Goldsmith SR Greenberg A Korzelius C Schrier RW Sterns RH Thompson CJ. Diagnosis
Charlotte Höybye, Laia Faseh, Christos Himonakos, Tomasz Pielak, and Jesper Eugen-Olsen
interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency . Clinical Endocrinology 2007 67 909 – 916 . ( https://doi.org/10.1111/j.1365-2265.2007.02986.x ) 17727678 10.1111/j.1365-2265.2007.02986.x 29 Leonsson
María L Bacigalupo, Verónica G Piazza, Nadia S Cicconi, Pablo Carabias, Andrzej Bartke, Yimin Fang, Ana I Sotelo, Gabriel A Rabinovich, María F Troncoso, and Johanna G Miquet
R Grottoli S Losa M Cannavo S , et al . Acromegaly is associated with increased cancer risk: a survey in Italy . Endocrine-Related Cancer 2017 24 . ( https://doi.org/10.1530/ERC-16-0553 ) 10 Bugni JM Poole TM Drinkwater NR
Hélène Singeisen, Mariko Melanie Renzulli, Vojtech Pavlicek, Pascal Probst, Fabian Hauswirth, Markus K Muller, Magdalene Adamczyk, Achim Weber, Reto Martin Kaderli, and Pietro Renzulli
M Guerra A Buratto M Foschini MP Tagliati F degli Uberti E Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region . Endocrine 2015 49 58 – 64 . ( https://doi.org/10.1007/s12020-015-0540-y ) 42 Borsari S Pardi
